Metronidazole-induced linear immunoglobulin A disease in a patient suffering from ulcerative colitis: a case report and focused review of the literature


Published: 29 August 2023
Abstract Views: 466
PDF: 45
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Linear immunoglobulin (Ig) A disease (LAD) is a rare autoimmune blistering dermatosis caused by linear deposition of IgA1 along the dermoepidermal junction of skin and mucosae. It can affect both children and adults. Although idiopathic in most cases, it can also be associated with infections, malignancies, or drug administration. Among medications, antibiotics are most commonly responsible, particularly vancomycin. We report the case of a 51-year-old female patient who developed mucocutaneous LAD after oral metronidazole administration, which was confirmed by histopathological examination and direct immunofluorescence of one of the bullous lesions. Lesions rapidly cleared after metronidazole discontinuation and a short course of oral methylprednisolone and dapsone. To our knowledge, this is the third reported case of metronidazole-induced LAD and the first in which metronidazole was not administered in combination with other antibiotics such as ceftriaxone.


Shin L, Gardner JT 2nd, Dao H Jr. Updates in the diagnosis and management of linear IgA disease: A systematic review. Medicina 2021;57:818.

Lammer J, Hein R, Roenneberg S, et al. Drug-induced linear IgA bullous dermatosis: a case report and review of the literature. Acta Derm Venereol 2019;99:508-15.

Fortuna G, Marinkovich MP. Linear immunoglobulin A bullous dermatosis. Clin Dermatol 2012;30:38-50.

Mori F, Saretta F, Liotti L, et al. Linear immunoglobulin A bullous dermatosis in children. Front Pediatr 2022;10:937528.

Tekin B, Johnson EF, Wieland CN, et al. Histopathology of autoimmune bullous dermatoses: what’s new? Hum Pathol 2022;128:69-89.

Kanda N, Nakadaira N, Otsuka Y, et al. Linear IgA bullous dermatosis associated with ulcerative colitis: A case report and literature review. Australas J Dermatol 2020;61:e82-6.

Waldman MA, Black DR, Callen JP. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Clin Exp Dermatol 2004;29:633-6.

Chanal J, Ingen-Housz-Oro S, Ortonne N, et al. Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms. Br J Dermatol 2013;169:1041-8.

Yawalkar N, Reimers A, Hari Y, et al. Drug-induced linear IgA bullous dermatosis associated with ceftriaxone- and metronidazole-specific T cells. Dermatology 1999;199:25-30.

Kim JS, Choi M, Nam CH, et al. Concurrent drug-induced linear immunoglobulin A dermatosis and immunoglobulin A nephropathy. Ann Dermatol 2015;27:315-8.

Buffon, S., Parietti, M., Carugno, A., Robustelli Test, E., Marzano, A. V., Sena, P., & Vezzoli, P. (2023). Metronidazole-induced linear immunoglobulin A disease in a patient suffering from ulcerative colitis: a case report and focused review of the literature. Dermatology Reports, 16(3). https://doi.org/10.4081/dr.2023.9831

Downloads

Download data is not yet available.

Citations